660 Stock Overview
An investment holding company, engages in the manufacturing and selling of modified starch and other biochemical products in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Wai Chun Bio-Technology Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.074 |
| 52 Week High | HK$0.28 |
| 52 Week Low | HK$0.055 |
| Beta | -0.17 |
| 11 Month Change | 0% |
| 3 Month Change | -26.00% |
| 1 Year Change | -52.56% |
| 33 Year Change | -87.46% |
| 5 Year Change | -98.10% |
| Change since IPO | -97.04% |
Recent News & Updates
Shareholder Returns
| 660 | HK Food | HK Market | |
|---|---|---|---|
| 7D | 0% | -0.1% | 0.4% |
| 1Y | -52.6% | -2.6% | 12.0% |
Return vs Industry: 660 underperformed the Hong Kong Food industry which returned -2.6% over the past year.
Return vs Market: 660 underperformed the Hong Kong Market which returned 12% over the past year.
Price Volatility
| 660 volatility | |
|---|---|
| 660 Average Weekly Movement | n/a |
| Food Industry Average Movement | 7.3% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 18.9% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine 660's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 130 | Ka Chun Lam | www.0660.hk |
Wai Chun Bio-Technology Limited, an investment holding company, engages in the manufacturing and selling of modified starch and other biochemical products in the People’s Republic of China. The company was formerly known as Wai Chun Mining Industry Group Company Limited and changed its name to Wai Chun Bio-Technology Limited in September 2019. Wai Chun Bio-Technology Limited was incorporated in 1992 and is headquartered in Wanchai, Hong Kong.
Wai Chun Bio-Technology Limited Fundamentals Summary
| 660 fundamental statistics | |
|---|---|
| Market cap | HK$12.69m |
| Earnings (TTM) | -HK$14.34m |
| Revenue (TTM) | HK$558.90m |
0.0x
P/S Ratio-0.9x
P/E RatioIs 660 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 660 income statement (TTM) | |
|---|---|
| Revenue | HK$558.90m |
| Cost of Revenue | HK$518.39m |
| Gross Profit | HK$40.52m |
| Other Expenses | HK$54.85m |
| Earnings | -HK$14.34m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.084 |
| Gross Margin | 7.25% |
| Net Profit Margin | -2.57% |
| Debt/Equity Ratio | 1,127.3% |
How did 660 perform over the long term?
See historical performance and comparison